vs

Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and SMITH & WESSON BRANDS, INC. (SWBI). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $124.7M, roughly 1.2× SMITH & WESSON BRANDS, INC.). SMITH & WESSON BRANDS, INC. runs the higher net margin — 1.5% vs -21.1%, a 22.6% gap on every dollar of revenue. On growth, SMITH & WESSON BRANDS, INC. posted the faster year-over-year revenue change (-3.9% vs -19.2%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $-28.6M). Over the past eight quarters, SMITH & WESSON BRANDS, INC.'s revenue compounded faster (-4.8% CAGR vs -7.5%).

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.

OPK vs SWBI — Head-to-Head

Bigger by revenue
OPK
OPK
1.2× larger
OPK
$148.5M
$124.7M
SWBI
Growing faster (revenue YoY)
SWBI
SWBI
+15.3% gap
SWBI
-3.9%
-19.2%
OPK
Higher net margin
SWBI
SWBI
22.6% more per $
SWBI
1.5%
-21.1%
OPK
More free cash flow
SWBI
SWBI
$44.9M more FCF
SWBI
$16.3M
$-28.6M
OPK
Faster 2-yr revenue CAGR
SWBI
SWBI
Annualised
SWBI
-4.8%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
OPK
OPK
SWBI
SWBI
Revenue
$148.5M
$124.7M
Net Profit
$-31.3M
$1.9M
Gross Margin
43.1%
24.3%
Operating Margin
-25.8%
3.3%
Net Margin
-21.1%
1.5%
Revenue YoY
-19.2%
-3.9%
Net Profit YoY
-322.8%
-53.6%
EPS (diluted)
$-0.04
$0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OPK
OPK
SWBI
SWBI
Q4 25
$148.5M
$124.7M
Q3 25
$151.7M
$85.1M
Q2 25
$156.8M
$140.8M
Q1 25
$150.0M
$115.9M
Q4 24
$183.6M
$129.7M
Q3 24
$173.6M
$88.3M
Q2 24
$182.2M
$159.1M
Q1 24
$173.7M
$137.5M
Net Profit
OPK
OPK
SWBI
SWBI
Q4 25
$-31.3M
$1.9M
Q3 25
$21.6M
$-3.4M
Q2 25
$-148.4M
$8.6M
Q1 25
$-67.6M
$2.1M
Q4 24
$14.0M
$4.5M
Q3 24
$24.9M
$-1.9M
Q2 24
$-10.3M
$27.9M
Q1 24
$-81.8M
$7.9M
Gross Margin
OPK
OPK
SWBI
SWBI
Q4 25
43.1%
24.3%
Q3 25
32.9%
25.9%
Q2 25
31.5%
28.8%
Q1 25
28.4%
24.1%
Q4 24
46.1%
26.6%
Q3 24
23.1%
27.4%
Q2 24
28.4%
35.5%
Q1 24
24.2%
28.7%
Operating Margin
OPK
OPK
SWBI
SWBI
Q4 25
-25.8%
3.3%
Q3 25
31.7%
-3.5%
Q2 25
-38.3%
9.3%
Q1 25
-44.8%
4.1%
Q4 24
-18.0%
5.8%
Q3 24
8.2%
-1.7%
Q2 24
-33.9%
17.4%
Q1 24
-41.2%
8.2%
Net Margin
OPK
OPK
SWBI
SWBI
Q4 25
-21.1%
1.5%
Q3 25
14.3%
-4.0%
Q2 25
-94.7%
6.1%
Q1 25
-45.1%
1.8%
Q4 24
7.6%
3.5%
Q3 24
14.3%
-2.1%
Q2 24
-5.7%
17.5%
Q1 24
-47.1%
5.7%
EPS (diluted)
OPK
OPK
SWBI
SWBI
Q4 25
$-0.04
$0.04
Q3 25
$0.03
$-0.08
Q2 25
$-0.19
$0.19
Q1 25
$-0.10
$0.05
Q4 24
$0.02
$0.10
Q3 24
$0.03
$-0.04
Q2 24
$-0.01
$0.60
Q1 24
$-0.12
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OPK
OPK
SWBI
SWBI
Cash + ST InvestmentsLiquidity on hand
$364.4M
$22.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$1.3B
$363.2M
Total Assets
$1.9B
$548.6M
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OPK
OPK
SWBI
SWBI
Q4 25
$364.4M
$22.4M
Q3 25
$412.0M
$18.0M
Q2 25
$267.3M
$25.2M
Q1 25
$428.8M
$26.7M
Q4 24
$426.6M
$39.1M
Q3 24
$400.1M
$35.5M
Q2 24
$40.6M
$60.8M
Q1 24
$75.6M
$47.4M
Total Debt
OPK
OPK
SWBI
SWBI
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
OPK
OPK
SWBI
SWBI
Q4 25
$1.3B
$363.2M
Q3 25
$1.3B
$364.4M
Q2 25
$1.3B
$372.5M
Q1 25
$1.3B
$366.9M
Q4 24
$1.4B
$371.5M
Q3 24
$1.4B
$380.0M
Q2 24
$1.4B
$399.9M
Q1 24
$1.3B
$376.4M
Total Assets
OPK
OPK
SWBI
SWBI
Q4 25
$1.9B
$548.6M
Q3 25
$2.0B
$554.6M
Q2 25
$2.0B
$559.6M
Q1 25
$2.1B
$578.9M
Q4 24
$2.2B
$587.4M
Q3 24
$2.3B
$571.3M
Q2 24
$2.0B
$577.4M
Q1 24
$2.0B
$570.6M
Debt / Equity
OPK
OPK
SWBI
SWBI
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OPK
OPK
SWBI
SWBI
Operating Cash FlowLast quarter
$-25.9M
$27.3M
Free Cash FlowOCF − Capex
$-28.6M
$16.3M
FCF MarginFCF / Revenue
-19.3%
13.1%
Capex IntensityCapex / Revenue
1.8%
8.8%
Cash ConversionOCF / Net Profit
14.22×
TTM Free Cash FlowTrailing 4 quarters
$-190.8M
$21.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OPK
OPK
SWBI
SWBI
Q4 25
$-25.9M
$27.3M
Q3 25
$-34.6M
$-8.1M
Q2 25
$-83.4M
$40.8M
Q1 25
$-34.6M
$-9.8M
Q4 24
$-44.4M
$-7.4M
Q3 24
$-77.1M
$-30.8M
Q2 24
$-26.4M
$43.7M
Q1 24
$-35.6M
$25.2M
Free Cash Flow
OPK
OPK
SWBI
SWBI
Q4 25
$-28.6M
$16.3M
Q3 25
$-37.8M
$-12.4M
Q2 25
$-86.7M
$33.5M
Q1 25
$-37.7M
$-16.1M
Q4 24
$-49.8M
$-10.7M
Q3 24
$-85.0M
$-35.5M
Q2 24
$-33.7M
$38.2M
Q1 24
$-40.0M
$7.0M
FCF Margin
OPK
OPK
SWBI
SWBI
Q4 25
-19.3%
13.1%
Q3 25
-24.9%
-14.6%
Q2 25
-55.3%
23.8%
Q1 25
-25.2%
-13.9%
Q4 24
-27.1%
-8.3%
Q3 24
-49.0%
-40.2%
Q2 24
-18.5%
24.0%
Q1 24
-23.0%
5.1%
Capex Intensity
OPK
OPK
SWBI
SWBI
Q4 25
1.8%
8.8%
Q3 25
2.1%
5.0%
Q2 25
2.1%
5.2%
Q1 25
2.1%
5.4%
Q4 24
2.9%
2.5%
Q3 24
4.6%
5.3%
Q2 24
4.0%
3.5%
Q1 24
2.6%
13.2%
Cash Conversion
OPK
OPK
SWBI
SWBI
Q4 25
14.22×
Q3 25
-1.60×
Q2 25
4.73×
Q1 25
-4.68×
Q4 24
-3.17×
-1.63×
Q3 24
-3.10×
Q2 24
1.57×
Q1 24
3.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

SWBI
SWBI

Segment breakdown not available.

Related Comparisons